Report Code: A11549 | Nov 2023 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Down Syndrome Market
Request Now !Down syndrome occurs when a person has an extra chromosome. Chromosomes are small units of genes in the body. These chromosomes determine how the body of a baby forms and functions as the baby grows during pregnancy and even after birth. Babies born with Down syndrome have an extra copy of chromosome 21. Patients suffering from Down syndrome have a mild to moderately low IQ and are also slower to speak during childhood than other children. Some common features of Down syndrome include a short neck, a flattened face, small ears, almond-shaped eyes, small hands and feet, and poor muscle tone (loose joints).
COVID-19 Impact Analysis
Product launches by the companies present across the globe are accelerating the growth of the Down syndrome market.
For instance, in April 2017, VeriSeq NIPT solution was launched by Illumina, Inc. in Europe. This product is a CE-IVD market sequencing technology-based approach. It is used for screening chromosomal abnormalities and can provide the chromosomal status in just 10 weeks of gestation.
U.S. dominates the Down syndrome market in the North America region due to increased R&D studies focused on finding better diagnostic and treatment solutions for Down syndrome.
In Europe, Germany leads the Down syndrome market due to the presence of properly connected and equipped distribution channels.
China leads the Asia-Pacific Down syndrome market due to rise in awareness of Down syndrome and therapies that can help the patients suffering from it.
The key players in the Down syndrome market adopt different strategies, such as collaborations, joint ventures with other players, and business expansion, in developing countries to improve their offerings in the Down syndrome market.
Key Benefits of the Report
Questions Answered in the Down Syndrome Report
Down Syndrome Market Report Highlights
Aspects | Details |
---|---|
By Disease Type |
|
By Treatment |
|
By End User |
|
By Region |
|
Key Market Players | Jiangsu Hengrui Medicine Co., Ltd., Bluebird Bio, Inc., CSL Limited, Pfizer Inc., Kyowa Kirin Co., Ltd., Octapharma AG, Bayer AG, Novartis Pharmaceuticals Corporation, Shire, Inc., GlaxoSmithKline Plc., Amgen, Inc., Novo Nordisk AS |
Start reading.
This Report and over 66,905+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers